3.2 General Recommendations for Implantable Cardioverter Defibrillator Therapy

COR	Recommendations General Recommendations for Implantable Cardioverter Defibrillator Therapy	LOE	References
I	ICD implantation is indicated for survivors of SCA due to VT/ventricular fibrillation (VF) if completely reversible causes have been excluded and an ICD is considered to be more beneficial than alternative treatments that may significantly reduce the risk of SCA.	B-NR	5 46 47
IIb	ICD implantation may be considered for patients with sustained VT that cannot be adequately controlled with medication and/or catheter ablation.	C-EO
IIb	ICD therapy may be considered for primary prevention of SCD in patients with genetic cardiovascular diseases and risk factors for SCA or pathogenic mutations and family history of recurrent SCA.	C-EO
III Harm	ICD therapy is not indicated for patients with incessant ventricular tachyarrhythmias due to risk of ICD storm.	C-EO
III Harm	ICD therapy is not indicated for patients with ventricular arrhythmias that are adequately treated with medication and/or catheter ablation.	C-LD	53 54
III Harm	ICD therapy is not indicated for patients who have an expected survival <1 year, even if they meet ICD implantation criteria specified in the above recommendations.	C-EO
III Harm	Endocardial leads should be avoided in patients with intracardiac shunts except in select cases, when there should be an individualized consideration of the risk/benefit ratio. In these exceptional cases anticoagulation is mandatory, but thromboembolism remains a risk.	B-NR	28